Granted Patent
B2
US 12,577,620 · App. 17/397,905 · Granted Mar 17, 2026
Nasal epithelium gene expression signature and classifier for the prediction of lung cancer
Inventors:
Avrum Spira (Newton, MA); Marc E. Lenburg (Brookline, MA); Joseph Perez-Rogers (San Mateo, CA); Christina Anderlind (Newton, MA)
Assignee:
Trustees of Boston University
View Patent ↗
Loading inventors, assignments & file history…
Abstract
This application provides assays and methods for diagnosis and prognosis of lung cancer using expression analysis of one or more genes from a biological sample comprising nasal epithelial cells. The assays and methods are non-invasive and accurately detect the presence or absence of lung cancer relative to, for example, more invasive techniques, such as bronchoscopy. Similarly, the assays and methods described provide non-invasive ways of accurately identifying the smoking history of a subject.
Claims (30)
1 . A method, comprising:
(a) performing a diagnostic procedure on a subject to determine a risk of malignancy for a subject for having or developing lung cancer, wherein said diagnostic procedure comprises a computer-aided tomography, a chest X-ray, or a bronchoscopy, and wherein said diagnostic procedure provides an indeterminate result for lung cancer;
(b) responsive to said indeterminate result for lung cancer, obtaining a nasal epithelial sample of said subject;
(c) generating a data set comprising (i) one or more genomic features in said nasal epithelial sample of said subject and (ii) one or more clinical features of said subject,
wherein generating said data set comprises sequencing ribonucleic acid (RNA) molecules derived from said nasal epithelial sample to determine said one or more genomic features,
wherein said one or more genomic features comprise genomic markers that are differentially expressed in nasal epithelium of subjects with lung cancer as compared to subjects without lung cancer;
(d) in a programmed computer, using a classifier to process said data set comprising said one or more genomic features and said one or more clinical features, to determine whether said subject has an increased risk of having or developing said lung cancer; and
(e) responsive to said determining in (d), administering to said subject a therapeutic intervention for lung cancer, wherein said therapeutic intervention comprises chemotherapy, radiation therapy, immunotherapy, surgical resection, or a combination thereof.
2 . The method of claim 1 , wherein said one or more genomic features comprise a genomic marker indicative of smoking status.
3 . The method of claim 2 , wherein said genomic marker indicative of smoking status is determined based at least in part on expression products of genes differentially expressed in current smokers and former smokers.
4 . The method of claim 1 , wherein said one or more genomic features comprise a genomic marker indicative of time since quitting smoking.
5 . The method of claim 1 , wherein said subject has lung nodules that are inconclusive for lung cancer as determined by computer aided tomography scan or bronchoscopy.
6 . The method of claim 1 , wherein said nasal epithelial sample comprises nasal epithelial cells.
7 . The method of claim 1 , further comprising obtaining said nasal epithelial sample from said subject by brushing.
8 . The method of claim 1 , wherein said subject has a lung nodule or lesion greater than 3 centimeters.
9 . The method of claim 1 , wherein said subject has a lung nodule or lesion less than 3 centimeters.
10 . The method of claim 1 , wherein said one or more clinical features are selected from the group consisting of: age, nodule or lesion size, nodule or lesion location, and any combination thereof.
11 . The method of claim 1 , wherein said one or more genomic features comprise gene expression products of said nasal epithelial sample obtained from said subject.
12 . The method of claim 1 , wherein said classifier uses a trained algorithm.
13 . The method of claim 12 , wherein said trained algorithm has been trained with a training data set comprising sequence information derived from transcripts of bronchial epithelial cells.
14 . The method of claim 12 , wherein said trained algorithm has been trained with a training data set comprising sequence information derived from transcripts of nasal epithelial cells.
15 . The method of claim 1 , wherein said data set further comprises a ribonucleic acid (RNA) integrity number.
16 . The method of claim 1 , wherein said lung cancer is selected from the group consisting of adenocarcinoma, squamous cell carcinoma, small cell cancer, and non-small cell cancer.
17 . The method of claim 1 , wherein said diagnostic procedure comprises said computer-aided tomography.
18 . The method of claim 1 , wherein said diagnostic procedure comprises said chest X-ray.
19 . The method of claim 1 , wherein said diagnostic procedure comprises said bronchoscopy.
20 . The method of claim 1 , wherein said therapeutic intervention comprises said chemotherapy.
21 . The method of claim 1 , wherein said therapeutic intervention comprises said radiation therapy.
22 . The method of claim 1 , wherein said therapeutic intervention comprises said immunotherapy.
23 . The method of claim 1 , wherein said therapeutic intervention comprises said surgical resection.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 9, 2021
From: SPIRA, AVRUM; LENBURG, MARC; PEREZ-ROGERS, JOSEPH; ANDERLIND, CHRISTINA
To: TRUSTEES OF BOSTON UNIVERSITY
Reel/Frame 058439/0029 →
Continuity (3)
Continuation
16300947
Provisional Application
62335391
· May 12, 2016
References Cited (400)
US 3640268A
· Davis
· 1972
[cited by applicant]
US 4641662A
· Jaicks
· 1987
[cited by applicant]
US 4800896A
· Jalowayski
· 1989
[cited by applicant]
US 5422273A
· Garrison et al.
· 1995
[cited by applicant]
US 5440942A
· Hubbard
· 1995
[cited by applicant]
US 5477863A
· Grant
· 1995
[cited by applicant]
US 5726060A
· Bridges
· 1998
[cited by applicant]
US 5795782A
· Church et al.
· 1998
[cited by applicant]
US 5876978A
· Willey et al.
· 1999
[cited by applicant]
US 6085907A
· Hochmeister et al.
· 2000
[cited by applicant]
US 6667154B1
· Wang et al.
· 2003
[cited by applicant]
US 6676609B1
· Rutenberg et al.
· 2004
[cited by applicant]
US 6746846B1
· Wang et al.
· 2004
[cited by applicant]
US 20020081612A1
· Katz et al.
· 2002
[cited by applicant]
US 20020160388A1
· Macina et al.
· 2002
[cited by applicant]
US 20030186248A1
· Erlander et al.
· 2003
[cited by applicant]
US 20040005294A1
· Lee
· 2004
[cited by applicant]
US 20040009489A1
· Golub et al.
· 2004
[cited by applicant]
US 20040063120A1
· Beer et al.
· 2004
[cited by applicant]
US 20040197785A1
· Willey et al.
· 2004
[cited by applicant]
US 20040241725A1
· Xiao et al.
· 2004
[cited by applicant]
US 20040241728A1
· Liew
· 2004
[cited by applicant]
US 20050266409A1
· Brown et al.
· 2005
[cited by applicant]
US 20060154278A1
· Brody et al.
· 2006
[cited by applicant]
US 20060183144A1
· Willey et al.
· 2006
[cited by applicant]
US 20060188909A1
· Willey et al.
· 2006
[cited by applicant]
US 20060190192A1
· Willey et al.
· 2006
[cited by applicant]
US 20070092891A1
· Willey et al.
· 2007
[cited by applicant]
US 20070092892A1
· Willey et al.
· 2007
[cited by applicant]
US 20070092893A1
· Willey et al.
· 2007
[cited by applicant]
US 20070148650A1
· Brody et al.
· 2007
[cited by applicant]
US 20090061454A1
· Brody et al.
· 2009
[cited by applicant]
US 20090186951A1
· Brody et al.
· 2009
[cited by applicant]
US 20090246779A1
· Rabinovitch et al.
· 2009
[cited by applicant]
US 20090311692A1
· Brody et al.
· 2009
[cited by applicant]
US 20100035244A1
· Brody et al.
· 2010
[cited by applicant]
US 20100055689A1
· Spira et al.
· 2010
[cited by applicant]
US 20110190150A1
· Brody et al.
· 2011
[cited by applicant]
US 20110217717A1
· Brody et al.
· 2011
[cited by applicant]
US 20120041686A1
· Brody et al.
· 2012
[cited by applicant]
US 20120190567A1
· Brody et al.
· 2012
[cited by applicant]
US 20120288860A1
· Van Hoek et al.
· 2012
[cited by applicant]
US 20120322673A1
· Brody et al.
· 2012
[cited by applicant]
US 20130023437A1
· Brody et al.
· 2013
[cited by applicant]
US 20130303826A1
· Jurisica et al.
· 2013
[cited by applicant]
US 20140378425A1
· Wilde et al.
· 2014
[cited by applicant]
US 20150080243A1
· Whitney et al.
· 2015
[cited by applicant]
US 20150088430A1
· Whitney
· 2015
[cited by applicant]
US 20150152474A1
· Pawlowski et al.
· 2015
[cited by applicant]
US 20160130656A1
· Whitney et al.
· 2016
[cited by applicant]
US 20170226591A1
· Brody et al.
· 2017
[cited by applicant]
US 20170247759A1
· Wilde et al.
· 2017
[cited by applicant]
US 20170328908A1
· Brody et al.
· 2017
[cited by applicant]
US 20230235401A1
· Brody et al.
· 2023
[cited by applicant]
CN 1688582A
· 2005
[cited by applicant]
DE 10219117C1
· 2003
[cited by applicant]
WO WO1999060160A1
· 1999
[cited by applicant]
WO WO2000006780A1
· 2000
[cited by applicant]
WO WO2000035473A2
· 2000
[cited by applicant]
WO WO2001028428A1
· 2001
[cited by applicant]
WO WO2002006791A2
· 2002
[cited by applicant]
WO WO0244331A2
· 2002
[cited by applicant]
WO WO2002072866A2
· 2002
[cited by applicant]
WO WO2002086443A2
· 2002
[cited by applicant]
WO WO2003015613A2
· 2003
[cited by applicant]
WO WO2003029273A2
· 2003
[cited by applicant]
WO WO03040317A2
· 2003
[cited by applicant]
WO WO2003040325A2
· 2003
[cited by applicant]
WO WO2003062389A2
· 2003
[cited by applicant]
WO WO2004005891A2
· 2004
[cited by applicant]
WO WO2004029055A1
· 2004
[cited by applicant]
WO WO2004091511A2
· 2004
[cited by applicant]
WO WO2004111197A2
· 2004
[cited by applicant]
WO WO2005000098A2
· 2005
[cited by applicant]
WO WO2005020784A2
· 2005
[cited by applicant]
WO WO2005047451A2
· 2005
[cited by applicant]
WO WO2006056080A1
· 2006
[cited by applicant]
WO WO2006113467A3
· 2007
[cited by applicant]
WO WO2007103541A2
· 2007
[cited by applicant]
WO WO2009039457A2
· 2009
[cited by applicant]
WO WO2009121070A1
· 2009
[cited by applicant]
WO WO2010054233A1
· 2010
[cited by applicant]
WO WO2013033640A1
· 2013
[cited by applicant]
WO WO2013049152A2
· 2013
[cited by applicant]
WO WO2013163568A2
· 2013
[cited by applicant]
WO WO2013177060A2
· 2013
[cited by applicant]
WO WO2014144564A2
· 2014
[cited by applicant]
WO WO2014186036A1
· 2014
[cited by applicant]
WO WO2016011068A1
· 2016
[cited by applicant]
WO WO2017197335A1
· 2017
[cited by applicant]
WO WO2018009915A1
· 2018
[cited by applicant]
WO WO2018048960A1
· 2018
[cited by applicant]
Han, Seon-Sook, et al. “RNA sequencing identifies novel markers of non-small cell lung cancer.” Lung Cancer 84.3 (2014): 229-235.
[cited by examiner]
Collins, Lauren G., et al. “Lung cancer: diagnosis and management.” American family physician 75.1 (2007): 56-63.
[cited by examiner]
Non-Final Office Action for U.S. Appl. No. 16/579,798 mailed Jun. 27, 2023.
[cited by applicant]
Whitehead, et al., “Variation in tissue-specific gene expression among natural populations,” Genome Biology, 6:R13, 2005.
[cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/579,798 mailed Dec. 19, 2023.
[cited by applicant]
Abrahamson, et al., Cystatins. Biochem. Soc. Symp. 70: 179-199 (2003).
[cited by applicant]
Anderson, et al., National Vital Statistics Report; 52(9): 1-88 (Nov. 7, 2003).
[cited by applicant]
Anthonisen, et al., Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1. JAMA; 272(19):1497-1505 (Nov. 16, 1994).
[cited by applicant]
Beane, et al., A Prediction Model for Lung Cancer Diagnosis that Integrates Genomic and Clinical Features, Cancer Prev Res 2008, 1:56-64 (2008).
[cited by applicant]
Beane, et al., Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biology 2007, 8:R201 (Sep. 25, 2007).
[cited by applicant]
Beer, et al., Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Medicine, 8: 816-824 (2002).
[cited by applicant]
Belinksky, et al., Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res., 62(8): 2370-7 (2002).
[cited by applicant]
Berman, Jeffrey S, Abstract Immunopathology of the nasal mucosa in sarcoidosis National Institutes of Health Grant No. 1 R21 HL077498-01 (Funding Start Date Sep. 15, 2004).
[cited by applicant]
Beum, et al., Epidermal Growth Factor Downregulates Core 2 Enzymes in a Human Airway Adenocarcinoma Cell Line. Am. J. Respir. Cell Mol. Biol., 29:48-56 (2003).
[cited by applicant]
Bhattacharjee, et al., Classification of human lung carcinoma by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA, 98(24): 13790-5 (Nov. 20, 2001).
[cited by applicant]
Bild, et al., Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature, 439: 353-357 (2006).
[cited by applicant]
Chari, et al., Effect of active smoking on the human bronchial epithelium transcriptome. BMC Genomics, 8:297 (Aug. 29, 2007).
[cited by applicant]
Clark, A., et al., “Altered Protein Kinase C (PKC) Isoforms in Non-Small Cell Lung Cancer Cells: PKCdelta Promotes Cellular Survival and Chemotherapeutic Resistance,”
[cited by applicant]
Crawford, et al., Normal Bronchial Epithelial Cell Expression of Glutathione Transferase P1, Glutathione Transferase M3, and Glutathione Peroxidase is Low in Subjects with Bronchogenic Carcinoma. Cancer Research, 60: 16…
[cited by applicant]
Cummings, SR. et al., Estimating the probability of malignancy in solitary pulmonary nodules. A Bayesian approach, Am Rev Respir Dis 1986;134:449-52 (1986).
[cited by applicant]
Demeo, et al., The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am J Hum Genet., 78(2): 253-264 (Feb. 2006).
[cited by applicant]
Denis, et al., RING3 Kinase Transactivates Promoters of Cell Cycle Regulatory Genes through E2F1 Cell. Growth Differ; 11: 417-424 (Aug. 2000).
[cited by applicant]
Doll, R. et al., Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ; 309:901-911 (Oct. 8, 1994).
[cited by applicant]
Ebbert, et al., Lung Cancer Risk Reduction After Smoking Cessation: Observations From a Prospective Cohort of Women. J Clin Oncol; 21(5):921-926 (Mar. 1, 2003).
[cited by applicant]
Fahy, JV. Remodeling of the Airway Epithelium in Asthma. Am. J. Respir. Crit. Care Med. 164:S46-S51 (2001).
[cited by applicant]
Freeman, et al., DNA from Buccal Swabs Recruited by Mail: Evaluation of Storage Effects on Long-term Stability and Suitability for Multiplex Polymerase Chain Reaction Genotyping,
[cited by applicant]
Garber, et al., Diversity of gene expression in adenocarcinoma of the lung. PNAS, 98(24): 13784-13789 (Nov. 20, 2001).
[cited by applicant]
Garcia-Closas, Collection of Genomic DNA from Adults in Epidemiological Studies by Buccal Cytobrush and Mouthwash, Cancer Epidemiology, Biomarkers and Prevention, 10: 687-696, (2001).
[cited by applicant]
Gebel, et al., Gene expression profiling in respiratory tissues from rats exposed to mainstream cigarette smoke. Carcinogenesis, 25(2): 169-178 (2004).
[cited by applicant]
Golub, et al., Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring, Science, American Association for the Advancement of Science, 286:5439 (Oct. 15, 1999).
[cited by applicant]
Greenlee, et al., Cancer Statistics, 2001. CA Cancer J Clin; 51(1):15-36 (2001).
[cited by applicant]
Gurney, JW. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis, Part 1, Theory. Radiology 1993;186:405-13 (2005).
[cited by applicant]
Hackett, et al., Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Biol., 29: 331-43 (2003).
[cited by applicant]
Hecht, SS., Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature Review Cancer; 3:733-744 (Oct. 2003).
[cited by applicant]
Jang, et al., Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Research 61: 7959-7963 (2001).
[cited by applicant]
Kanner, et al., Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the lung health stu…
[cited by applicant]
Kao, et al., Tumor-associated Antigen L6 and the Invasion of Human Lung Cancer Cells. Clin Cancer Res. 9:2807-2816 (Jul. 2003).
[cited by applicant]
Katz, et al., Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer, Modern Pathology;21:950-960 (2008).
[cited by applicant]
Kazemi-Noureini, et al., Differential gene expression between squamous cell carcinoma of esophageus and its normal epithelium; altered pattern of mal, akr1c2, and rab11a expression. World J Gastroenterol, 10(12): 1716-1…
[cited by applicant]
Kitahara, et al. Alternations of Gene Expression during Colorectal Carcinogenesis; Revealed by cDNA Microarrays after Laser-Capture Microdissection of Tumor Tissues and Normal Epithelia. Cancer Research, 61: 3544-3549 (…
[cited by applicant]
Lander, et al., Initial sequencing and analysis of the human genome. Nature, 409: 860-921 (Feb. 15, 2001).
[cited by applicant]
Li, L., Survival prediction of diffuse large-B-cell lymphoma based on both clinical and gene expression information, Bioinformatics 2006; 22:466-71 (2006).
[cited by applicant]
Liao, et al., Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer, Ai Zheng 25: 10, p. 1238-42. Abstract (2006).
[cited by applicant]
Liu et al., Effects of physiological versus pharmacological ß-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets. Carcinogenesis, 21: 2245-2253 (…
[cited by applicant]
Mannino, DM. et al., Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up, Arch Intern Med. 163(12):1475-80 (2003).
[cited by applicant]
Medical News: Targeted, Oral Agent Enzastaurin Shows Favorable Results in Late-Stage Lung Cancer. (Jun. 11, 2007), Retrieved from the Internet <URL: <http://www.medicalnewstoday.com/articles/73761.php>>.
[cited by applicant]
Michalczyk, et al., Fresh and cultured buccal cells as a source of mRNA and protein for molecular analysis. Biotechniques. 37(2):262-4, 266-9 (2004).
[cited by applicant]
Miklos, et al., Microarray reality checks in the context of a complex disease. Nature Biotechnology, 22:5 (May 2005).
[cited by applicant]
Miura, et al., Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. Cancer Res., 62(11): 3244-50 (Jun. 1, 2002).
[cited by applicant]
Mongiat, et al., Fibroblast Growth Factor-binding Protein Is a Novel Partner for Perlecan Protein Core. The Journal of Biological Chemistry; 276(13):10263-10271 (Mar. 30, 2001).
[cited by applicant]
Neubauer, et al., Cure of Helicobacter pylori Infection and Duration of Remission of Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. J. Natl. Cancer Inst., 89(18): 1350-1378 (Sep. 17, 1997).
[cited by applicant]
Okudela, K., et al., “K-ras Gene Mutation Enhances Motility of Immortalized Airway Cells and Lung Adenocarcinoma Cells Via Akt Activation: Possible Contribution to Non-Invasive Expansion of Lung Adenocarcinoma,”
[cited by applicant]
Pittman, J. et al., Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes, Proc Natl Acad Sci U S A 2004; 101:8431-6 (2004).
[cited by applicant]
Potti et al., A Genomic Strategy to Refine Prognosis in Early-Stage Non Small-Cell Lung Cancer, The New England Journal of Medicine 2006; 335(6):570-580 (2006).
[cited by applicant]
Powell, et al., Patterns of allelic loss differ in lung adenocarcinomas of smokers and nonsmokers. Lung Cancer, 39(1): 23-29 (2003).
[cited by applicant]
Powell, et al., Gene expression in lung adenocarcinomas of smokers and nonsmokers. American Journal of Respiratory Cell and Molecular Biology, 29: 157-162 (Aug. 2003).
[cited by applicant]
Proctor RN., Tobacco and the global lung cancer epidemic. Nature Reviews Cancer, 1: 82-86 (Oct. 2001).
[cited by applicant]
Rusznak, et al., Effect of Cigarette Smoke on the Permeability and IL-1B and sICAM-1 Release from Cultured Human Bronchial Epithelial Cells of Never-Smokers, Smokers, and Patients with Chronic Obstructive Pulmonary Dise…
[cited by applicant]
Saheki, et al., Pathogenesis and pathophysiology of citrin (a mitochondrial aspartate glutamate carrier) deficiency. Metabolic Brain Disease; 17(4):335-346 (Dec. 2002).
[cited by applicant]
Schembri, Frank et al., MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium, Proc Natl Acad Sci U S A, 106(7):2319-24 (Feb. 2009).
[cited by applicant]
Shields, PG., Molecular epidemiology of lung cancer. Annals of Oncology, 10(5):S7-S11 (1999).
[cited by applicant]
Shriver, et al., Sex-Specific Expression of Gastrin-Releasing Peptide Receptor: Relationship to Smoking History and Risk of Lung Cancer. J. Natl. Cancer Inst., 92: 24-33 (2000).
[cited by applicant]
Spira, et al., Noninvasive method for obtaining RNA from buccal mucosa epithelial cells for gene expression profiling. Biotechniques, 36(3): 484-7 (2004).
[cited by applicant]
Spira, et al., Effects of cigarette smoke on the human airway epithelial cell transcriptome, PNAS, 101: 27, p. 10143-10148 (Jul. 6, 2004).
[cited by applicant]
Spira, et al., Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nature Medicine 13: 361-366 (2007).
[cited by applicant]
Spira, et al., Gene Expression Profiling of Human Lung Tissue from Smokers with Severe Emphysema. Am J Respir Cell Mol Biol., 31(6):601-10 (2004).
[cited by applicant]
Spira, et al., Impact of cigarette smoke on the normal airway transcriptome. Chest. 125 (5 Suppl):115S (May 2004).
[cited by applicant]
Spira, Avrum E., Abstract The airway transcriptome as a biomarker for lung cancer National Institutes of Health Grant No. 1 R21 CA106506-01 (Funding Start Date Aug. 9, 2005).
[cited by applicant]
Spira, Avrum E., Abstract Airway gene expression in smokers: an early diagnostic biomarker for lung cancer National Institutes of Health Grant No. 1 R01 CA124640-01 (Funding Start Date May 1, 2007).
[cited by applicant]
Spivack, et al., Gene-environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells, Cancer Research, 64: 18, p. 6805-6813 (2004).
[cited by applicant]
Sridhar, et al. Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium. BMC Genomics, 9: 259 (May 2008).
[cited by applicant]
Stephenson, AJ. et al., Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy, Cancer 2005; 104:290-8 (2005).
[cited by applicant]
Stewart, JH. Lung Carcinoma in African Americans, A Review of the Current Literature. Cancer; 91(12): 2476-2482 (Jun. 15, 2001).
[cited by applicant]
Swensen, SJ. et al., The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules, Arch Intern Med 1997; 157:849-55 (1997).
[cited by applicant]
Swensen, SJ. et al., Abstract Solitary pulmonary nodules: clinical prediction model versus physicians, Mayo Clinic Proc 1999; 74:319-29 (1999).
[cited by applicant]
Theocharis, et al., Metallothionein: a multifunctional protein from toxicity to cancer. Int Biol Markers, 18(3):162-169 (2003).
[cited by applicant]
Thurston, SW. et al., Modeling lung cancer risk in case-control studies using a new dose metric of smoking, Cancer Epidemiol Biomarkers Prev 2005; 14(10): 2296-302 (2005).
[cited by applicant]
Trunk, G. et al., The management and evaluation of the solitary pulmonary nodule, Chest 1974; 66:236-9 (1974).
[cited by applicant]
Ung, YC. et al., Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review, J Nat'l Cancer Institute, 99(23): 1753-67 (2007).
[cited by applicant]
Volm, et al., Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas. J Cancer Res Clin Oncol, 119: 507-510 (1993).
[cited by applicant]
Wahidi, MM. et al., Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines 2nd Edition, Chest 2007; 132:94-107S (2007).
[cited by applicant]
West, M., et al. Embracing the complexity of genomic data for personalized medicine, Genome Res 2006; 16:559-66 (2006).
[cited by applicant]
Wistuba, et al., Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst., 89(18): 1366-73 (Sep. 17, 1997).
[cited by applicant]
Wistuba, et al., High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent b…
[cited by applicant]
Zeeberg, et al.. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biology, 4(4): R28.1-R28.8 (2003).
[cited by applicant]
Zhang, et al. Comparison of smoking-induced gene expression on Affymetrix Exon and 3'-based expression arrays. Genome Inform. 18: 247-57 (2007).
[cited by applicant]
Retracted in Jan. 2011—Potti, A., et al., “Genomic Signatures to Guide the Use of Chemotherapeutics,” Nature Medicine, 12(11): 1294-1300 (2006). (Retracted in Jan. 2011—Potti, A., et al., “Genomic Signatures to Guide th…
[cited by applicant]
Ambion, Inc. “GeneAssist Pathway Atlas for P13K Signaling,” Accessed from <http://www5.appliedbiosystems.com/tools/pathway/pathway_proteins.php?pathway=P13K> on May 3, 2011.
[cited by applicant]
Arimura, et al. Elevated Serum β-Defensins Concentrations in Patients with Lung Cancer,
[cited by applicant]
Baker, Stuart. “The Central Role of Receiver Operating Characteristic (ROC) Curves in Evaluating Tests for the Early Detection of Cancer,”
[cited by applicant]
Braakhuis, et al. “A Genetic Explanation of Slaughter's Concept of Field Cancerization Evidence and Clinical Implications,”
[cited by applicant]
Chen, et al. “Discordant Protein and mRNA Expression in Lung Adenocarcinomas,”
[cited by applicant]
Dauletbaev, et al. “Expression of Human Beta Defensin (HBD-1 and HBD-2) mRNA in Nasal Epithelia of Adult Cystic Fibrosis Patients, Healthy Individuals, and Individuals with Acute Cold,”
[cited by applicant]
Franklin, et al. “Widely Dispersed p53 Mutation in Respiratory Epithelium,”
[cited by applicant]
Hellmann, et al. “Gene Profiling of Cultured Human Bronchia Epithelial and Lung Cacinoma Cells,”
[cited by applicant]
Ikeda, et al. “Malignancy associated changes in bronchial epithelial cells and clinical application as a biomarker,”
[cited by applicant]
Kraft, et al. “Expression of epithelial markers in nocturnal asthma,”
[cited by applicant]
Liu, et al. “Quantitative Proteome Analysis Reveals Annexin A3 as a Novel Biomarker in Lung Adenocarcinoma,”
[cited by applicant]
Reynolds, et al. “Pre-protachykinin-A mRNA is increased in the airway epithelium of smokers with chronic bronchitis.”
[cited by applicant]
Riise, et al. “Bronchial Brush Biopsies for Studies of Epithelial Inflammation in Stable Asthma and Nonobstructive Chronic Bronchitis,”
[cited by applicant]
Slonim, Donna. “From Patterns to Pathways: Gene Expression Data Analysis Comes of Age,”
[cited by applicant]
Takizawa, et al. “Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD),”
[cited by applicant]
Watters, et al. “Developing Gene Expression Signatures of Pathway Deregulation in Tumors,”
[cited by applicant]
Ohtsuka, et al., “ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis,”
[cited by applicant]
Hamilton and Sharp, “Diagnosis of lung cancer in primary care: a structured review,”
[cited by applicant]
Akita, et al., “Molecular Biology of Lung Cancer,”
[cited by applicant]
Printout from database NCBI GEO accession No. GSE4115 [Online] NCB, dated Feb. 27, 2006.
[cited by applicant]
Brody, Jerome S., Abstract “Airway epithelial gene expression in COPD” National Institutes of Health Grant No. 1 R01 HL071771-01 (Funding Start Date Sep. 30, 2002).
[cited by applicant]
Bohula et al., “The Efficacy of Small Interfering RNAs Targeted to the Type 1 Insulin-like Growth Factor Receptor (IGF1R) Is Influenced by Secondary Structure in the IGF1R Transcript,” The Journal of Biological Chemistr…
[cited by applicant]
Wardlaw, et al., “Effect of cigarette smoke on CYP1A1, CYP1A2 and CYP2B1/2 of nasal mucosae in F344 rats,” Carcinogenesis 19(4): 655-662 (1998).
[cited by applicant]
Lin, et al., “Effects of Dexamethasone on Acute Lung Injury Rat Cells Signal Transduction Systems ERK and PI3-K,” Medical Journal of Chinese People's Liberation Army 6(31): 592-594 (2006).
[cited by applicant]
Guajardo, et al., “Altered gene expression profiles in nasal respiratory epithelium reflect stable versus acute childhood asthma”, J. Allergy Clin Immunol 115(2): 243-251 (2005).
[cited by applicant]
Voynow, et al., “Mucin Gene Expression (MUC1, MUC2, and MUC5/5AC) in Nasal Epithelial Cells of Cystic Fibrosis, Allergic Rhinitis, and Normal Individuals”, Lung 176: 345-354 (1998).
[cited by applicant]
Shah et al., “SIEGE: Smoking Induced Epithelial Gene Expression Database”, Nucleic Acids Research, 33: D573-D579 (2005).
[cited by applicant]
Enard et al., “Intra- and Interspecific Variation in Primate Gene Expression Patterns”, Science 296: 340-343 (2002).
[cited by applicant]
Cheung, et al., “Natural variation in human gene expression assessed in lymphoblastoid cells”, Nature Genetics, 33: 422-425 (2003).
[cited by applicant]
Wu, Thomas D., “Analysing gene expression data from DNA microarrays to identify candidate genes”, Journal of Pathology, 195:53-65 (2001).
[cited by applicant]
Newton, et al., “On Differential Variability of Expression Ratios: Improving Statistical Inference about Gene Expression Changes from Microarray Data”, Journal of Computational Biology, 8: 37-52 (2001).
[cited by applicant]
Fritz, et al., “Nasal mucosal gene expression in patients with allergic rhinitis with and without nasal polyps”, Journal of Allergy Clin. Immunol, 112(6): 1057-1063 (2003).
[cited by applicant]
Lam, et al., “A Phase I Study of myo-Inositol for Lung Cancer Chemoprevention”, Cancer Epidemiology, Biomarkers & Prevention 15(8): 1526-1531 (2006).
[cited by applicant]
Peluso, et al., “Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms”, Carcinogenesis 25(12): 2459-2465 (2004).
[cited by applicant]
Marinov, et al., “Targeting mTOR signaling in lung cancer”, Critical Reviews in Oncology/Hematology 63: 172-182 (2007).
[cited by applicant]
Singhal, et al., “Alterations in Cell Cycle Genes in Early Stage Lung Adenocarcinoma Identified by Expression Profiling”, Cancer Biology & Therapy 2(3): 291-299 (2003).
[cited by applicant]
Zhang, et al., “Similarities and Differences Between Smoking-Related Gene Expression in Nasal and Bronchial Epithelium,”
[cited by applicant]
Danel, et al., “Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normal and individuals with cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine 15…
[cited by applicant]
Merriam-Webster.com (htpp://www.merriam-webster.com/dictionary/questionnaire, downloaded Oct. 26, 2013).
[cited by applicant]
Tarca, et al., “Analysis of microarray experiments of gene expression profiling,” American Journal of Obstetrics and Gynecology 195(2): 373-388 (2006).
[cited by applicant]
May, “How many species are there on earth?” Science 241(4872): 1441-1449 (1988).
[cited by applicant]
Benner, et al. “Evolution, language and analogy in functional genomics,” Trends in Genetics 17(7): 414-418 (2001).
[cited by applicant]
Modrek, et al., “Genome-wide detection of alternative splicing in expressed sequences of human genes,” Nucleic Acids Research 29(13): 2850-2859 (2001).
[cited by applicant]
Woenckhaus, et al., “Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers,” The Journal of Pathology 210(2): 192-204 (2006).
[cited by applicant]
Details for HG-U133A:202831_AT (<https://www.affymetrix.com/analysis/netaffx/fullrecord.affx?pk=HG-U133A:202831_AT>, downloaded Dec. 10, 2012).
[cited by applicant]
Details for HG-U133A:210519_S_AT (<https://www.affymetrix.com/analysis/netaffx/fullrecord.affx?pk=HG-U133A:210519_S_AT> downloaded Dec. 10, 2012).
[cited by applicant]
HG-U133a-207469_S_AT (https:www/affymetrix.com/analysis/netaffx/fullrecord.affx?pk=HG-U133A:207469_S_AT, downloaded Dec. 10, 2012.
[cited by applicant]
HG-U133A:823_AT (<https://www.affymetrix.com/analysis/netaffx/fullrecord.affx?pk=HG-U133A:823_AT>, downloaded Dec. 10, 2012.
[cited by applicant]
Demoly, et al., “c-fos Proto-oncogene Expression in Bronchial Biopsies of Asthmatics,” American Journal of Respiratory Cell and Molecular Biology 7:128-133 (1992).
[cited by applicant]
Hennessy, et al., “Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery,” Nature, vol. 4: 988-1004 (2005).
[cited by applicant]
Langford, et al., “Is the Property of Being Positively Correlated Transitive,” The American Statistician 55(4): 322-325 (2001).
[cited by applicant]
Saal, et al., “Poor Prognosis in Carcinoma is Associated with A Gene Expression Signature of Aberrant PTEN Tumor Suppressor Pathway Activity,” PNAS 104(18): 7564-7569 (2007).
[cited by applicant]
Sotos, et al., “The Transitivity Misconception of Pearson's Correlation Coefficient,” Statistics Education Research Journal 8(2): 33-55 (2009).
[cited by applicant]
Thisted, Ronald A. “What is a P-value”, Departments of Statistics and Health Studies, The University of Chicago, May 25, 1988.
[cited by applicant]
Tichelaar, et al., “Increased Staining for Phospho-Akt, p65/RELA and cIAP-2 in Pre-neoplastic Human Bronchial Biopsies,” BMC Cancer 5(155): 1-13 (2005).
[cited by applicant]
Tsao, et al, “Increased Phospho-AKT (Ser473) Expression in Bronchial Dysplasia: Implications for Lunch Cancer Prevention Studies,” Cancer, Epidemiology, Biomarkers & Prevention 12:660-664 (2003).
[cited by applicant]
West, et al, “Rapid Akt Activation by Nicotine and Tobacco Carcinogen Modulates the Phenotype of Normal Human Airway Epithelial Cells,” The Journal of Clinical Investigation 111(1): 81-90 (2003).
[cited by applicant]
Hoshikawa, et al., “Hypoxia induces difference genes in the lungs of rats compared with mice,” Physiol Genomics 12: 209-219 (2003).
[cited by applicant]
Cheng, et al., “Reduced expression levels of nucleotide excision repair genes in; lung cancer: a case-control analysis,” Carcinogenesis 21(8): 1527-1530 (2000).
[cited by applicant]
Fielding, et al., “Heterogeneous Nuclear Ribonucleoprotein A2/B1 Up-Regulation in Bronchial Lavage Specimens: A Clinical Marker of Early Lung Cancer Detection,” Clinical Cancer Research 5:4048-4052 (1999).
[cited by applicant]
Yu-Rong, et al., “Tumor associated antigen L6 and the invasion of human lung cancer cells.” Clinical Cancer Research 9(7): 2807-16 (2003).
[cited by applicant]
Dempsey, et al., “Lung disease and PKCs,” Pharmacological Research 55(6): 545-59 (2007).
[cited by applicant]
MacKay et al., “Targeting the protein kinase C family: are we there yet?” Nature Reviews Cancer 7(7): 554-62 (2007).
[cited by applicant]
Gustafson, et al., “Airway P13K Pathway Activation Is an Early and Reversible Even in Lung Cancer Development,” www.Science TransmlationMedicine.org <http://www.ScienceTransmlationMedicine.org> 2(26) (2010).
[cited by applicant]
Fukumoto, et al., “Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 is Highly Correlated with Smokers' Non-Small Cell Lung Carcinomas,” Clinical Cancer Research 11:1776-1786 (2005).
[cited by applicant]
Whitehead et al., “Variation in tissue-specific gene expression among natural populations,” Genome Biology 6(2):R13.1-R13.14 (2005).
[cited by applicant]
Brambilla, et al., “Advances in Brief p53 Mutant Immunophenotype and Deregulation of p53 Transcription Pathway (Bc12, Bax, and Waft) in Precursor Bronchial Lesions of Lung Cancer1”,
[cited by applicant]
Demuth, et al., “The gene expression index c-myc x E2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells”,
[cited by applicant]
Hirsch, et al., “Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology 1”,
[cited by applicant]
Lacroix, et al., “Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCR”,
[cited by applicant]
Willey, et al., “Quantitative RT-PCR Measurement of Cytochromes p450 1A1, 1B1, and; 2B7, Microsomal Epoxide Hydrolase, and NADPH Oxidoreductase Expression in Lung Cells of Smokers and Nonsmokers,” Am. J. Respir. Cell Mo…
[cited by applicant]
Mollerup, et al., “Sex Differences in Lung CYP1A1 Expression and DNA Adduct Levels among Lung Cancer Patients,” Cancer Research, 1999, 59: 3317-3320 (1999).
[cited by applicant]
Saito-Hisaminato, “Genome-Wide Profiling of Gene Expression in 29 Normal Human Tissues with a cNDA Microarray,” DNA Research, 2002, 9:35-45.
[cited by applicant]
Details for HG-U133A:217291 _At (CEACAM5) (https://www.affymetrix.com/analysis/netaffx/fullrecord.affx?pk=HG-U133A:217291_AT,; downloaded Apr. 22, 2016).
[cited by applicant]
St. Croix, et al., “Genes Expressed in Human Tumor Endothelium,”
[cited by applicant]
Moller, et al., “Altered ratio of endothelin ETA- and ETB receptor mRNA in bronchial biopsies from patients with asthma and chronic airway obstruction,” Eur. Journal of Pharmacology, 365:R1-R3, (1999).
[cited by applicant]
Wojnarowski et al., “Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation,” Eur. Respir. J., 14:1136-1144, (1999).
[cited by applicant]
Anbazhagan, et al., “Classification of Small Cell Lung Cancer and Pulmonary Carcinoid by Gene Expression Profiles,”
[cited by applicant]
Chen, et al., “Up-regulations of Tumor Interleukin-8 Expression by Infiltrating Macrophages: Its Correlation with Tumor Angiogenesis and Patient Survival in Non-Small Cell Lung Cancer,”
[cited by applicant]
Grepmeier, et al., “Deletions at Chromosome 2q and 12p are Early Frequent Molecular Alterations in Bronchial Epithelium and NSCLC of Long-Term Smokers.”
[cited by applicant]
Khan, et al., “Classification and Diagnostic Prediction of Cancers Using Gene Expression Profiling and Artificial Neural Networks,”
[cited by applicant]
Yoneda, et al., “Development of High-Density DNA Microarray Membrane for Profiling Smoke-and Hydrogen Peroxide-Induced Genes in a Human Bronchial Epithelial Cell Line,”
[cited by applicant]
Notterman, et al., “Tumor Biology and Microarray Analysis of Solid Tumors: Colorectal Cancer as a Model System,”
[cited by applicant]
Strausberg, et al., “Reading the Molecular Signatures of Cancer,”
[cited by applicant]
Zochbauer-Muller, et al., “5' CpG Island Methylation of the FHIT Gene is Correlated with Loss of Gene Expression in Lung and Breast,”
[cited by applicant]
Cooper, “Gene Expression Studies in Lung Cancer,”
[cited by applicant]
Deng, et al., “Ubiquitous Induction of Resistance to Platinum Drugs in Human Ovarian, Cervical, Germ-Cell and Lung Carcinoma Tumor Cells Overexpressing Isoforms 1 and 2 of Dihydrodiol Dehydrogenase,”
[cited by applicant]
Schulz, et al., “Activation of Bronchial Epithelial Cells in Smokers Without Airway Obstruction and Patients with COPD,”
[cited by applicant]
Su, et al., “Molecular Classification of Human Carcinomas by Use of Gene Expression Signatures,”
[cited by applicant]
Yang, et al., “Reduction of Dihydrodiol Dehydrogenase Expression in Resected Hepatocellular Carcinoma,”
[cited by applicant]
Kuriakose, et al., “Selection and Validation of Differentially Expressed Genes in Head and Neck Cancer,” CMLS, 61:1372-1383, (2004).
[cited by applicant]
Sugita, et al., “Combined Use of Oligonucleotide and Tissue Microarrays Identifies Cancer/Testis Antigens as Biomarkers in Lung Carcinoma,” Cancer Research, 62:3971-3979, (Jul. 15, 2002).
[cited by applicant]
Vartiainen, et al., “Validation of Self-Reported Smoking by Serum Cotinine Measurement in a Community-Based Study,”
[cited by applicant]
Beane-Ebel, “Single-Cell RNA Sequencing of the Bronchial Epithelium in Smokers With Lung Cancer,” U.S. Army Medical Research and Material Command. Jul. 1, 2016 [retrieved on Sep. 19, 2017]. Retrieved from the Internet a…
[cited by applicant]
Coleman, “Of Mouse and Man—What is the Value of the Mouse in Predicting Gene Expression in Humans?” Drug Discovery Today, 8(6):233-235, (Mar. 2003).
[cited by applicant]
Durham, et al., “The Relationship Between COPD and Lung Cancer,” Lung Cancer, 90:121-127, (2015).
[cited by applicant]
Kocarnik, et al., “Replication of Associations Between GWAS SNPs and Melanoma Risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study,” Journal of Investigative Dermatology, 134:2049-2052, (Feb.…
[cited by applicant]
Ooi, et al., “Molecular Profiling of Premalignant Lesions in Lung Squamous Cell Carcinomas Identifies Mechanisms Involved in Stepwise Carcinogenesis,” Cancer Prevention Research, 7(5):487-495, (Mar. 11, 2014).
[cited by applicant]
Anonymous: “Bronchogenic carcinoma is a malignant neoplasm of the lung arising from the epithelium of the bronchus or bronchiole”, Apr. 22, 2003 (Apr. 22, 2003), retrieved from the internet: URL:http://www.meddean.luc.e…
[cited by applicant]
Brenner, Sydney, et al. “Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays.” Nature biotechnology 18.6 (2000): 630.
[cited by applicant]
Gerrein, J., et al., “/Poster Discussion Session/ Sunday, May 18 / 2:00-4:30 PM / Room 30 A-B (Upper Level) San A107 The Lung's Silver Lining: Airway and Alveolar Epithelial Biology Leveraging Gene Expression in the Bro…
[cited by applicant]
Chen, et al., “Expression of dihydrodiol dehydrogenase in the resected stage I non-small cell lung cancer,” Oncology Reports, vol. 9, No. 3, May 1, 2002, pp. 515-519.
[cited by applicant]
Hsu, et al., “Overexpression of dihydrodiol dehydrogenase as a prognostic maker of non-small cell lung cancer,” Cancer Research vol. 6, No. 6, Mar. 15, 2001, pp. 2727-2731.
[cited by applicant]
Shibuya, Kiyoshi, et al. “Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung.” Cancer 92.4 (2001): 849-855.
[cited by applicant]
Tockman, Melvyn S., et al. “Considerations in bringing a cancer biomarker to clinical application.” Cancer Research 52.9 Supplement (1992): 2711s-2718s.
[cited by applicant]
Anonymous: “Bronchogenic carcinoma / definition of bronchogenic carcinoma by Medical dictionary,” Feb. 13, 2019 (Feb. 13, 2019), retrieved from the internet: URL:https://medical-dictionary.thefreedictionary.com/bronchog…
[cited by applicant]
Spira, et al., Translating Airway Gene Expression into Biomarkers for Tobacco Smoke Exposure and Lung Cancer Detection Smoking and the Airway “field of Injury” as a Paradigm. Retrieved from the internet: URL: https://ww…
[cited by applicant]
Affymetrix Show Results SULF1 (http://www.affymetrix.com/analysis/netaffx/showresults.affx, downloaded Jul. 6, 2020).
[cited by applicant]
Iacobuzio-Donahue, Christine A., et al. “Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.…
[cited by applicant]
Powell, Charles A., et al. “Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer.” Clinical Cancer Research 5.8 (1999): 2025-2034.
[cited by applicant]
Gorringe, Kylie L. “Loss of heterozygosity.” eLS (2016): 1-8.
[cited by applicant]
Jung, et al. (Korean Journal of Medicine, 2002, 62(1): 58-68).
[cited by applicant]
British Thoracic Society Bronchoscopy Committee (Thorax, 2001) 56 (suppl): i1-i21.
[cited by applicant]
Tjard Van Heek et al., (Cancer Biology & Therapy, 2004 3(7): 651-656).
[cited by applicant]
International Search Report for PCT/US2017/032517, dated Oct. 2, 2017.
[cited by applicant]
International Search Report for PCT/US2017/041267, dated Dec. 15, 2017.
[cited by applicant]
European Search Report in Application EP 10 18 4732, dated Mar. 21, 2011.
[cited by applicant]
European Search Report in Application EP 10 18 4813, dated Mar. 21, 2011.
[cited by applicant]
European Search Report in Application EP 10 18 4888, dated Mar. 21, 2011.
[cited by applicant]
European Search Report in Application EP 04 81 0818, dated Oct. 28, 2010.
[cited by applicant]
European Search Report in Application EP 08 83 2403, dated Oct. 22, 2010.
[cited by applicant]
European Search Report in Application EP 09 72 4548, Jun. 16, 2011.
[cited by applicant]
European Search Report for European Application No. EP 10195816, dated Oct. 13, 2011.
[cited by applicant]
European Search Report in Application EP 12 17 0635, dated Apr. 22, 2013.
[cited by applicant]
Chinese Search Report in Application 2008801147951 dated Aug. 24, 2012.
[cited by applicant]
Extended European Search Report from EP 16186152.1, dated May 31, 2017.
[cited by applicant]
European Search Report for European Application No. EP 17185133.0, dated Feb. 21, 2018.
[cited by applicant]
Supplementary European Search Report for European Application No. EP 17 79 6983, Issued Feb. 3, 2020.
[cited by applicant]
European Search Report EP10195822 dated Jun. 20, 2011.
[cited by applicant]
European Search Report EP10195803 dated Jun. 20, 2011.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 12/234,588, dated Jun. 27, 2011.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 10/579,376, dated Jul. 9, 2008.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 12/884,714, dated Sep. 23, 2011.
[cited by applicant]
Final Office Action for U.S. Appl. No. 12/234,588, dated Nov. 4, 2011.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 12/414,555, dated Nov. 30, 2011.
[cited by applicant]
Final Office Action for U.S. Appl. No. 12/414,555, dated Mar. 15, 2012.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 13/346,444, dated Dec. 12, 2012.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 12/234,588, dated Mar. 28, 2014.
[cited by applicant]
Final Office Action for U.S. Appl. No. 13/346,444, dated Nov. 27, 2013.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 11/294,834, dated Jan. 29, 2014.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/584,960, dated Apr. 27, 2016.
[cited by applicant]
Final Office Action for U.S. Appl. No. 13/524,749, dated Apr. 3, 2014.
[cited by applicant]
Final Office Action for U.S. Appl. No. 13/323,655, dated Jul. 17, 2014.
[cited by applicant]
Final Office Action for U.S. Appl. No. 11/294,834, date of mailing Aug. 22, 2016.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 11/294,834, mailed Dec. 15, 2015.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 11/294,834, dated Jun. 24, 2008.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 13/323,655, dated Apr. 9, 2013.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 13/524,749, dated Sep. 9, 2013.
[cited by applicant]
Final Office Action for U.S. Appl. No. 11/294,834 dated Aug. 18, 2014.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 13/323,655 dated Nov. 7, 2013.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 11/294,834, dated Jul. 29, 2014.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/613,210, dated Dec. 6, 2016.
[cited by applicant]
Final Office Action for U.S. Appl. No. 14/500,475, dated Feb. 28, 2017.
[cited by applicant]
Final Office Action for U.S. Appl. No. 14/613,210, dated Apr. 3, 2017.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/439,791, dated Jun. 14, 2017.
[cited by applicant]
Final Office Action for U.S. Appl. No. 14/500,475, dated Aug. 2, 2017.
[cited by applicant]
Notice of Allowance for U.S. Appl. No. 14/613,210, dated Oct. 31, 2017.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/644,721, dated Dec. 27, 2017.
[cited by applicant]
Final Office Action for U.S. Appl. No. 15/439,891, issued Feb. 14, 2018.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/500,475, dated Mar. 26, 2018.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/690,182, dated Apr. 20, 2018.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/336,469, dated Apr. 10, 2018.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/888,831, dated Mar. 27, 2018.
[cited by applicant]
Final Office Action for U.S. Appl. No. 15/644,721, dated Jun. 20, 2018.
[cited by applicant]
Final Office Action for U.S. Appl. No. 15/888,831, dated Jul. 24, 2018.
[cited by applicant]
Final Office Action for U.S. Appl. No. 15/336,469, dated Oct. 9, 2018).
[cited by applicant]
Final Office Action for U.S. Appl. No. 14/690,182, dated Oct. 9, 2018.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/439,891, dated Dec. 28, 2018.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/690,182, dated Mar. 22, 2019.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/888,831, dated Mar. 27, 2019.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/644,721, dated Mar. 7, 2019.
[cited by applicant]
Final Office Action for U.S. Appl. No. 14/500,475, dated May 14, 2019.
[cited by applicant]
Final Office Action for U.S. Appl. No. 15/439,891, dated Jun. 18, 2019.
[cited by applicant]
Final Office Action for U.S. Appl. No. 15/888,831, dated Oct. 10, 2019.
[cited by applicant]
Notice of Allowance for U.S. Appl. No. 14/500,475, dated Oct. 15, 2019.
[cited by applicant]
Non-final Office Action for U.S. Appl. No. 15/336,469 issued Dec. 4, 2019.
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/510,584 issued Jan. 16, 2020.
[cited by applicant]
Notice of Allowance issued in U.S. Appl. No. 15/888,831, dated Feb. 20, 2020.
[cited by applicant]
Final Office Action for U.S. Appl. No. 16/510,584, issued Apr. 23, 2020.
[cited by applicant]
Final Office Action for U.S. Appl. No. 15/336,469, dated Jul. 10, 2020.
[cited by applicant]
Notice of Allowance issued in U.S. Appl. No. 15/888,831, dated Jun. 1, 2020.
[cited by applicant]
Non-Final Office Action issued in U.S. Appl. No. 16/810,827, dated Aug. 10, 2020.
[cited by applicant]
Notice of Allowance issued in U.S. Appl. No. 15/644,721, dated Sep. 30, 2020.
[cited by applicant]
Non-Final Office Action Issued in U.S. Appl. No. 16/510,584, dated Sep. 30, 2020.
[cited by applicant]
Non-Final Office Action Issued in U.S. Appl. No. 16/300,947, dated Oct. 22, 2020.
[cited by applicant]
Final Office Action Issued in U.S. Appl. No. 16/810,827, dated Nov. 23, 2020.
[cited by applicant]
Jones, A.M., et al., “Value and accuracy of cytology in addition to histology in the diagnosis of lung cancer at flexible bronchoscopy,”
[cited by applicant]
Final Office Action Issued in U.S. Appl. No. 16/510,584, dated Feb. 11, 2021.
[cited by applicant]
Guajardo, J.R., et al., “Altered gene expression profiles in nasal respiratory epithelium reflect stable versus acute childhood asthma,”
[cited by applicant]
Gebel, et al., “Gene expression profiling in respiratory tissues from rats exposed to mainstream cigarette smoke,”
[cited by applicant]
Sabo-Attwood, et al., “Gene expression profiles reveal increased mClca3 (Gob5) expression and mucin production in a murine model of asbestos-induced fibrogenesis,”
[cited by applicant]
Lee, et al., “Expression of mRNA of Trefoil Factor Peptides in Human Nasal Mucosa,”
[cited by applicant]
Korn, S. H., et al. “Glucocorticoid receptor mRNA levels in bronchial epithelial cells of patients with COPD: influence of glucocorticoids.” Respiratory medicine 92.9 (1998): 1102-1109.
[cited by applicant]
Hindiyeh, Musa, et al. “Evaluation of a multiplex real-time reverse transcriptase PCR assay for detection and differentiation of influenza viruses A and B during the 2001-2002 influenza season in Israel.” Journal of cli…
[cited by applicant]
Li, Jin, et al. “The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.” International journal of oncology 46.5 (2015): 2107-2115.
[cited by applicant]
Mak, Victor. Expression of CFTR mRNA in nasal epithelium and vas deferens. Diss. 1999.
[cited by applicant]
Tokunaga, Katsuo, et al. “Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers.” Cancer Research 47.21 (1987): 5616-5619.
[cited by applicant]
Weng, Ching-Fu, et al. “Association between the risk of lung cancer and influenza: A population-based nested case-control study.” International Journal of Infectious Diseases 88 (2019): 8-13.
[cited by applicant]
Wong, SC Cesar, et al. “Development of a quantitative assay for SARS coronavirus and correlation of GAPDH mRNA with SARS coronavirus in clinical specimens.” Journal of clinical pathology 58.3 (2005): 276-280.
[cited by applicant]
Zabner, Joseph, et al. “Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.” The Journal of clinical investigation 100.6 (1997): 1529-1537.
[cited by applicant]
Non-Final Office Action issued in U.S. Appl. No. 16/810,827, dated Apr. 22, 2021.
[cited by applicant]
Final Office Action issued in U.S. Appl. No. 15/336,469, dated Jun. 25, 2021.
[cited by applicant]
Non-Final Office Action issued in U.S. Appl. No. 16/751,145 dated Aug. 18, 2021.
[cited by applicant]
Non-Final Office Action issued in U.S. Appl. No. 16/510,584 dated Aug. 25, 2021.
[cited by applicant]
Non-Final Office Action issued in U.S. Appl. No. 16/810,827 issued Aug. 23, 2021.
[cited by applicant]
Pirooznia, Mehdi, et al. “A comparative study of different machine learning methods on microarray gene expression data.” BMC genomics 9.1 (2008): 1-13.
[cited by applicant]
Bertone, Paul, and Mark Gerstein. “Integrative data mining: the new direction in bioinformatics.” IEEE Engineering in Medicine and Biology Magazine 20.4 (2001): 33-40.
[cited by applicant]
Details for HT_HG-U133A:212344_AT (Affymetrix Expression Probeset Details, downloaded Mar. 1, 2022).
[cited by applicant]
Non-Final Office Action issued in U.S. Appl. No. 16/657,816 dated May 11, 2022.
[cited by applicant]